IceCure Medical (ICCM) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($5.7 million vs $5.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICCM | SNOA |
|---|---|---|
| Share price | $1.13 | $1.19 |
| Market cap | $5.22M | $5.69M |
| 1-day change | -0.77% | +2.46% |
| EPS (TTM) | $-6.84 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.46 | $4.30 |
| 52-week low | $1.04 | $0.85 |
| Distance from 52-week high | -96.18% | -72.36% |
| Analyst consensus | none | — |
| Avg. price target upside | +1912.79% | — |
| Average volume | 139.00K | 107.65K |
| Shares outstanding | 4.64M | 4.79M |
| Employees | 67 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About IceCure Medical
ICCM stock →IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
Health Care · Medical/Dental Instruments · 67 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
ICCM vs SNOA FAQ
Which is bigger, IceCure Medical or Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $5.69M compared with $5.22M for IceCure Medical (ICCM).
Are IceCure Medical and Sonoma Pharmaceuticals in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.